Celltex News
Stem Cell Journals: Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood
Posted on Oct 28th, 2020
Celltex Therapeutics Corporation was mentioned in the Stem Cell Journals publication in an article titled "Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood".
Read the article
Tags: clinical research, clinical trial, COVID-19, stem cell therapy
More Recent News
The Importance of Quantity in Stem Cell Therapy
Existing research suggests that multiple doses of stem cell therapy have the potential to be more effective than a single dose.
Read MoreThe Benefits of Repeat Doses in Stem Cell Therapy
Existing research suggests that multiple doses of stem cell therapy have the potential to be more effective than a single dose.
Read More